118. Myelomeningocele Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 18 / Drugs : 34 - (DrugBank : 12) / Drug target genes : 13 - Drug target pathways : 53
Drugs, Primary sponsors and Trial info (Enrollment year, Phase, Trial ID, Countries)
Anticholinergic
Assiut University
2024 - NCT06301802 Egypt
Atosiban
University of Sao Paulo General Hospital
2017 - NCT04468568 Brazil
Botulinum A toxin
University of Aarhus
2005 Phase 4 NCT00175123 Denmark
CIC
Assiut University
2024 - NCT06301802 Egypt
CIK cells
Everett Meyer
2011 Phase 2 NCT01392989 United States
Contrast enhanced voiding urosonography with urodynamic testing
University of Virginia
2021 - NCT04738539 United States
Cyclosporine
Everett Meyer
2011 Phase 2 NCT01392989 United States
Drospirenone/ethinylestradiol/methyltetrahydrofolate
Bayer
2007 Phase 3 NCT00468481 United States
Folic acid
Centers for Disease Control and Prevention
2005 - NCT00207558 China
University of Alabama at Birmingham
2026 - NCT06734611 United States;Zambia
Folic acid and inositol
Institute of Child Health
2009 Phase 1 NCT00452829 United Kingdom
Folic acid fortified iodized salt
Hydrocephalus and Neuroscience Institute
2022 - NCT06174883 United States
Inositol
AGUNCO Obstetrics and Gynecology Centre
2010 - NCT01244399 Italy
Micronutrient fortified iodized salt
Hydrocephalus and Neuroscience Institute
2022 - NCT06904612 India;United States
Multivitamin
Emory University
2006 - NCT00394862 -
Mycophenolate mofetil
Everett Meyer
2011 Phase 2 NCT01392989 United States
Norgestimate-ethinyl estradiol, with or without folic acid
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
2006 Phase 3 NCT00301587 United States
Placental mesenchymal stem cells seeded ON A commercially available dural graft extracellular matrix
University of California, Davis
2021 Phase 1/Phase 2 NCT04652908 United States
Salt with folic acid and iodine
University of Alabama at Birmingham
2023 - NCT05935631 United States
Terbutaline
University of Sao Paulo General Hospital
2017 - NCT04468568 Brazil
Thymoglobulin
Everett Meyer
2011 Phase 2 NCT01392989 United States
Untreated contemporaneous cohort
University of California, Davis
2021 Phase 1/Phase 2 NCT04652908 United States
Assiut University
2024 - NCT06301802 Egypt
Atosiban
University of Sao Paulo General Hospital
2017 - NCT04468568 Brazil
Botulinum A toxin
University of Aarhus
2005 Phase 4 NCT00175123 Denmark
CIC
Assiut University
2024 - NCT06301802 Egypt
CIK cells
Everett Meyer
2011 Phase 2 NCT01392989 United States
Contrast enhanced voiding urosonography with urodynamic testing
University of Virginia
2021 - NCT04738539 United States
Cyclosporine
Everett Meyer
2011 Phase 2 NCT01392989 United States
Drospirenone/ethinylestradiol/methyltetrahydrofolate
Bayer
2007 Phase 3 NCT00468481 United States
Folic acid
Centers for Disease Control and Prevention
2005 - NCT00207558 China
University of Alabama at Birmingham
2026 - NCT06734611 United States;Zambia
Folic acid and inositol
Institute of Child Health
2009 Phase 1 NCT00452829 United Kingdom
Folic acid fortified iodized salt
Hydrocephalus and Neuroscience Institute
2022 - NCT06174883 United States
Inositol
AGUNCO Obstetrics and Gynecology Centre
2010 - NCT01244399 Italy
Micronutrient fortified iodized salt
Hydrocephalus and Neuroscience Institute
2022 - NCT06904612 India;United States
Multivitamin
Emory University
2006 - NCT00394862 -
Mycophenolate mofetil
Everett Meyer
2011 Phase 2 NCT01392989 United States
Norgestimate-ethinyl estradiol, with or without folic acid
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
2006 Phase 3 NCT00301587 United States
Placental mesenchymal stem cells seeded ON A commercially available dural graft extracellular matrix
University of California, Davis
2021 Phase 1/Phase 2 NCT04652908 United States
Salt with folic acid and iodine
University of Alabama at Birmingham
2023 - NCT05935631 United States
Terbutaline
University of Sao Paulo General Hospital
2017 - NCT04468568 Brazil
Thymoglobulin
Everett Meyer
2011 Phase 2 NCT01392989 United States
Untreated contemporaneous cohort
University of California, Davis
2021 Phase 1/Phase 2 NCT04652908 United States
